Tempus AI’s latest analyst update keeps the fair value target unchanged at US$67.20 per share, even as model assumptions are fine tuned. The steady target sits against a mixed backdrop, where some ...
Tempus AI, Inc. (NASDAQ:TEM) ranks among the best short squeeze stocks to invest in. Following the company’s first-quarter results, H.C. Wainwright reduced its price target for Tempus AI, Inc. (NASDAQ ...
A significant technology, Transmission electron microscopy (TEM) has found its way into cell biology since 1940. When compared with light microscopes, TEM can achieve a very high resolution due to the ...
Zacks Investment Research on MSN
HIMS vs. TEM: Which AI healthcare stock offers better upside now?
Digital healthcare continues to evolve across both consumer-facing telehealth platforms and data-driven precision medicine ...
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three key ...
London-based energy software company Tem has closed a $75 million Series B round led by Lightspeed Venture Partners, with additional funding from AlbionVC, Atomico, Hitachi Ventures, Schroders Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results